Although no significant difference in the frequency of any DNA sequence variation was found between patients and controls and no data was found to support the hypothesis that SLC26A5 may act as a modifier of GJB2-based hearing loss in this population of hearing impaired patients, the population included in this study was small. This evidence concerns the gene SLC26A5 and hearing loss disorder.